Figure 1.
Figure 1. Purification of CD4+CD25+ cells from peripheral blood. Representative 2-color FACS plots of PBMCs and purified CD4+CD25+ and CD4+CD25- cells. (A) Examination of peripheral blood reveals CD4+CD25+ cells constitute 1% to 3% of PBMCs. There are a variable number of non-CD4+ cells that express CD25, generally of lower intensity expression (mostly B cells). (B) Some donors evidence a more distinct CD4+CD25+ population. (C) CD4+CD25+ cells. Cells were purified by anti-CD25-FITC and anti-FITC cleavable microbeads and subsequently lineage depleted. Intensity of CD25-PE staining is slightly decreased by prior staining with anti-CD25-FITC. (D) CD4+CD25- cells. Cells were purified by CD25 depletion of PBMCs, followed by CD4+ positive selection. Data are representative of 20 donor evaluations and 10 cell purification experiments.

Purification of CD4+CD25+ cells from peripheral blood. Representative 2-color FACS plots of PBMCs and purified CD4+CD25+ and CD4+CD25- cells. (A) Examination of peripheral blood reveals CD4+CD25+ cells constitute 1% to 3% of PBMCs. There are a variable number of non-CD4+ cells that express CD25, generally of lower intensity expression (mostly B cells). (B) Some donors evidence a more distinct CD4+CD25+ population. (C) CD4+CD25+ cells. Cells were purified by anti-CD25-FITC and anti-FITC cleavable microbeads and subsequently lineage depleted. Intensity of CD25-PE staining is slightly decreased by prior staining with anti-CD25-FITC. (D) CD4+CD25- cells. Cells were purified by CD25 depletion of PBMCs, followed by CD4+ positive selection. Data are representative of 20 donor evaluations and 10 cell purification experiments.

Close Modal

or Create an Account

Close Modal
Close Modal